{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Ubiquitin > Lenalidomide-BrCAS：2093387-36-9
Molecular Formula：C13H11BrN2O3
Molecular Weight：323.14
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Solid
Qty：
Size：
| CAS | 2093387-36-9 |
| Name | Lenalidomide-Br |
| Molecular Formula | C13H11BrN2O3 |
| Molecular Weight | 323.14 |
| Solubility | Soluble in DMSO ≥1mg/mL(Need ultrasonic or Water bath) |
| Purity | ≥98% |
| Appearance | Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD32063479 |
| SMILES | C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3Br |
| InChIKey | SCZFMUWTABGOGF-UHFFFAOYSA-N |
| InChI | InChI=1S/C13H11BrN2O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3，10H，4-6H2，(H，15，17，18) |
| PubChem CID | 131986901 |
| Target Point | cereblon (CRBN) |
| Passage | Ubiquitin |
| Background | Lenalidomide-br is an analogue of the cereblon (CRBN) ligand Lenalidomide for E3 ubiquitin ligase, which is used for recruitment of CRBN proteins. Lenalidomide-Br can be attached to protein ligands by linker to form PROTAC. |
| Unit | Bottle |
| Specification | 2mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
